Serial Number:
88226880
Mark:
OLBRICEN
Status:
Abandoned-No Statement of Use filed
Status Date:
08-22-2022
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations and substances for the treatment of pain, cardiovascular disorders, alimentary tract and metabolism problems, respiratory diseases, endocrine, musculoskeletal, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmological, otologicals, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; anti-inflammatory and anti-rheumatics drugs; pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations, namely, hematological agents being pharmaceuticals for the treatment of hematological diseases; Enzyme replacement therapy preparations; Enzyme replacement therapy products, namely, infusions, liquids, tablets and powders for human use in the treatment of genetic disorders for medical purposes; Therapeutic cellular and stem cell compositions for medical use
Mark Description:
N/A
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
05-21-2019
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
08-22-2022
Business Name:
VORYS, SATER, SEYMOUR AND PEASE LLP
Correspondent Name:
